Cite
HARVARD Citation
Chase, D. et al. (2020). Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. International journal of gynecological cancer. 30 (5), pp. 596-601. [Online].